Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

T-Bird Pharma Inc. V.TPI



TSXV:TPI - Post by User

Post by jimrockfordon Nov 16, 2014 3:26pm
194 Views
Post# 23134146

RTB / MMPR Comparables

RTB / MMPR ComparablesCompany          -                 Market Cap                      -                Status
 

Abattis          -            $10.4 million                 -            Awaiting the RTB Letter 
Affinor          -             $17 million                 -            Await HC licenses, approvals


Matica          -             $5.6 million          -             RTB- and inspection date set with HC for MMPR
Supreme Pharm.   -    $25.2 million                -         Pre-approval from HC
Prescient     -              $60 million plus (halted)   -    RTB 



Organigram       -        $54.1 million                     -    MMPR
Bedrocan          -         $53.3 million                    -     MMPR – importing cannabis           
                                                                                  Building Canadian facility             
Mettrum            -        $59.3 million                     -     MMPR
Tweed               -         $102.7 million                 -      MMPR
T-Bird Pharma   -         $23 million                      -     MMPR - but very small



<< Previous
Bullboard Posts
Next >>